Takeda Pharms Na Drug Patent Portfolio
Takeda Pharms Na owns 1 orange book drug protected by 2 US patents Given below is the list of Takeda Pharms Na's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7396841 | Injections | 17 Feb, 2022 | Expired |
| US7396841 | Injections | 17 Aug, 2021 | Expired |
Latest Legal Activities on Takeda Pharms Na's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Takeda Pharms Na.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 05 Aug, 2016 | US7396841 |
| Post Issue Communication - Certificate of Correction | 05 Feb, 2009 | US7396841 |
|
Recordation of Patent Grant Mailed
Critical
| 08 Jul, 2008 | US7396841 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 08 Jul, 2008 | US7396841 |
|
Issue Notification Mailed
Critical
| 18 Jun, 2008 | US7396841 |
| Dispatch to FDC | 06 Jun, 2008 | US7396841 |
|
Application Is Considered Ready for Issue
Critical
| 20 May, 2008 | US7396841 |
|
Issue Fee Payment Verified
Critical
| 15 May, 2008 | US7396841 |
|
Issue Fee Payment Received
Critical
| 15 May, 2008 | US7396841 |
| Mail Examiner's Amendment | 19 Mar, 2008 | US7396841 |
|
Mail Notice of Allowance
Critical
| 19 Mar, 2008 | US7396841 |
| Mail Examiner Interview Summary (PTOL - 413) | 19 Mar, 2008 | US7396841 |
|
Case Docketed to Examiner in GAU
Critical
| 12 Mar, 2008 | US7396841 |
|
Notice of Allowance Data Verification Completed
Critical
| 12 Mar, 2008 | US7396841 |
| Interview Summary Record | 10 Mar, 2008 | US7396841 |
Takeda Pharms Na's Family Patents
Takeda Pharms Na Drug List
Given below is the complete list of Takeda Pharms Na's drugs and the patents protecting them.
1. Prevacid Iv
Prevacid Iv is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7396841
(Pediatric)
| Injections |
17 Feb, 2022
(3 years ago)
| Expired |
| US7396841 | Injections |
17 Aug, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Prevacid Iv's drug page